Company intelligence / Profile preview

RedCell

Tysons, Virginia, USAredcell.nu ↗

Ownership: Private
Development stage: Other

Overview

Red Cell Partners is an active investment and incubation firm that creates and scales technology-led healthcare companies. It has launched or backed ventures such as Zephyr AI, which applies artificial intelligence to revolutionize drug discovery and precision medicine by analyzing massive datasets to identify novel therapeutics, biomarkers, and streamline clinical trials in oncology, diabetes, and other areas.

Therapeutic areas: OncologyEndocrinologyOther
Modalities: Artificial intelligence-driven drug discoverySmall moleculeBiologic
Industry: Investors

Partnerships

Not specified at the parent level; partnerships exist at subsidiary level (e.g., Zephyr AI partners with biopharma firms/data providers).

Beyond the preview

Go deeper on RedCell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RedCell.

Explore the full profile